Back

Panel discussion.

27 August 2022 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors in practice (part 2): how do we implement new treatments in HFpEF? Heart Failure with Preserved Ejection Fraction (HFpEF) Open Access ESC Congress 2022

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

3 More presentations in this session

Presentation thumbnail
Introduction and recap.
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
What is the evidence for empagliflozin in HFpEF?
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
Implementing empagliflozin for HFpEF treatment in my practice.
Professor M. Boehm (Homburg, DE)
Slides Video

Access the full session

Session thumbnail
SGLT2 inhibitors in practice (part 2): how do we implement new treatments in HFpEF?
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 13:30 CET
You may be interested in
thumbnail
Congress Session
No time like the present: heart failure in the hospital setting
thumbnail
Webinar
SGLT2 inhibitors across the left ventricular function spectrum
thumbnail
Congress Session
Diabetes, obesity, and heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources